Parvin Antikörper und Ähnliche Produkte
Santa Cruz Biotechnology bietet eine umfassende Sammlung von monoklonalen Parvin-Antikörpern für Forschungszwecke an. Die monoklonalen Parvin-Antikörper sind validiert für Western Blotting (WB), Immunpräzipitation (IP), Immunfluoreszenz (IF), Immunhistochemie mit Paraffin eingebetteten Schnitten (IHCP), Durchflusszytometrie (FCM) und Enzymimmunoassay (ELISA). Parvin-Proteine sind integrale Bestandteile der Zelladhäsion und regulieren die Dynamik des Aktin-Zytoskeletts, die für Prozesse wie Zellmigration und Gewebsintegrität unerlässlich sind. Die Beteiligung von Parvin an zellulären Signalwegen macht es zu einem wichtigen Schwerpunkt in der Krebsforschung und Entwicklungsbiologie. Das Verständnis der Funktion von Parvin kann Einblicke in verschiedene pathologische Zustände und potenzielle therapeutische Ziele liefern. Forscher auf der ganzen Welt nutzen monoklonale Parvin-Antikörper, um ihre Studien zur Zellbiologie und zu Krankheitsmechanismen voranzutreiben. Die Charakterisierung der molekularen Interaktionen von Parvin bringt immer wieder neue Aspekte der zellulären Organisation und Regulierung ans Licht. Die monoklonalen Antikörper von Santa Cruz Biotechnology für die Parvin-Forschung unterstützen den wissenschaftlichen Fortschritt, indem sie eine präzise Untersuchung der zellulären Prozesse und Krankheitsmechanismen ermöglichen.
Siehe auch...
Learn more about our ImmunoCruz® Antibody Conjugates and Cruz Marker™ MW Standards Promotional
Parvin Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
β-parvin Antikörper (D-2) | sc-374581 | mouse IgG1 κ | 197-241 (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
γ-parvin Antikörper (G-8) | sc-393593 | mouse IgG1 κ | 50-79 (h) | WB, IP, IF, ELISA | m, r, h | neu | ||
γ-parvin Antikörper (A-11) | sc-398027 | mouse IgG2b κ | 1-141 (m) | WB, IP, IF, ELISA | m, r, h | neu | ||
γ-parvin Antikörper (B-9) | sc-376081 | mouse IgG1 κ | 41-79 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | neu | ||
γ-parvin Antikörper (B-9) | sc-398674 | mouse IgG1 κ | 1-141 (m) | WB, IP, IF, ELISA | m, r, h | neu | ||
γ-parvin Antikörper (C-5) | sc-390388 | mouse IgG1 κ | 1-141 (h) | WB, IP, IF, ELISA | m, r, h | neu | ||
γ-parvin Antikörper (D-6) | sc-166294 | mouse IgG1 κ | 147-176 (h) | WB, IP, IF, ELISA | m, r, h | neu | ||
γ-parvin Antikörper (F-9) | sc-271380 | mouse IgG2b κ | 147-176 (m) | WB, IP, IF, ELISA | m, r, h | neu |
Parvin CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
α-parvin CRISPR/Cas9 KO Plasmid (h) | sc-405769 | h | Gene Knockout | GFP | 0 | ||
α-parvin CRISPR/Cas9 KO Plasmid (h2) | sc-405769-KO-2 | h | Gene Knockout | GFP | 0 | ||
α-parvin HDR Plasmid (h2) | sc-405769-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
α-parvin Double Nickase Plasmid (h) | sc-405769-NIC | h | Gene Knockout | Puromycin | 0 | ||
α-parvin Double Nickase Plasmid (h2) | sc-405769-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
α-parvin CRISPR/Cas9 KO Plasmid (m) | sc-425386 | m | Gene Knockout | GFP | 0 | ||
α-parvin HDR Plasmid (m) | sc-425386-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
α-parvin Double Nickase Plasmid (m) | sc-425386-NIC | m | Gene Knockout | Puromycin | 0 | ||
α-parvin Double Nickase Plasmid (m2) | sc-425386-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
β-parvin CRISPR/Cas9 KO Plasmid (h) | sc-406390 | h | Gene Knockout | GFP | 0 | ||
β-parvin HDR Plasmid (h) | sc-406390-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
β-parvin Double Nickase Plasmid (h) | sc-406390-NIC | h | Gene Knockout | Puromycin | 0 | ||
β-parvin Double Nickase Plasmid (h2) | sc-406390-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
β-parvin CRISPR/Cas9 KO Plasmid (m) | sc-431296 | m | Gene Knockout | GFP | 0 | ||
β-parvin HDR Plasmid (m) | sc-431296-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
β-parvin Double Nickase Plasmid (m) | sc-431296-NIC | m | Gene Knockout | Puromycin | 0 | ||
β-parvin Double Nickase Plasmid (m2) | sc-431296-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
γ-parvin CRISPR/Cas9 KO Plasmid (h) | sc-412979 | h | Gene Knockout | GFP | 0 | ||
γ-parvin HDR Plasmid (h) | sc-412979-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
γ-parvin Double Nickase Plasmid (h) | sc-412979-NIC | h | Gene Knockout | Puromycin | 0 | ||
γ-parvin Double Nickase Plasmid (h2) | sc-412979-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
γ-parvin CRISPR/Cas9 KO Plasmid (m) | sc-425673 | m | Gene Knockout | GFP | 0 | ||
γ-parvin HDR Plasmid (m) | sc-425673-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
γ-parvin Double Nickase Plasmid (m) | sc-425673-NIC | m | Gene Knockout | Puromycin | 0 | ||
γ-parvin Double Nickase Plasmid (m2) | sc-425673-NIC-2 | m | Gene Knockout | Puromycin | 0 |
Parvin CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
α-parvin CRISPR Activation Plasmid (h) | sc-405769-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
α-parvin CRISPR Activation Plasmid (h2) | sc-405769-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
α-parvin Lentiviral Activation Particles (h) | sc-405769-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
α-parvin Lentiviral Activation Particles (h2) | sc-405769-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
α-parvin CRISPR Activation Plasmid (m) | sc-425386-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
α-parvin CRISPR Activation Plasmid (m2) | sc-425386-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
α-parvin Lentiviral Activation Particles (m) | sc-425386-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
α-parvin Lentiviral Activation Particles (m2) | sc-425386-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
β-parvin CRISPR Activation Plasmid (h) | sc-406390-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
β-parvin CRISPR Activation Plasmid (h2) | sc-406390-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
β-parvin Lentiviral Activation Particles (h) | sc-406390-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
β-parvin Lentiviral Activation Particles (h2) | sc-406390-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
β-parvin CRISPR Activation Plasmid (m) | sc-431296-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
β-parvin CRISPR Activation Plasmid (m2) | sc-431296-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
β-parvin Lentiviral Activation Particles (m) | sc-431296-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
β-parvin Lentiviral Activation Particles (m2) | sc-431296-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
γ-parvin CRISPR Activation Plasmid (h) | sc-412979-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
γ-parvin CRISPR Activation Plasmid (h2) | sc-412979-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
γ-parvin Lentiviral Activation Particles (h) | sc-412979-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
γ-parvin Lentiviral Activation Particles (h2) | sc-412979-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
γ-parvin CRISPR Activation Plasmid (m) | sc-425673-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
γ-parvin CRISPR Activation Plasmid (m2) | sc-425673-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
γ-parvin Lentiviral Activation Particles (m) | sc-425673-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
γ-parvin Lentiviral Activation Particles (m2) | sc-425673-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
Parvin siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
α-parvin siRNA (h) | sc-60107 | h | Gene Silencing | N/A | 1 | ||
α-parvin shRNA Plasmid (h) | sc-60107-SH | h | Gene Silencing | Puromycin | 1 | ||
α-parvin shRNA (h) Lentivirale Partikel | sc-60107-V | h | Gene Silencing | Puromycin | 1 | ||
α-parvin siRNA (m) | sc-60108 | m | Gene Silencing | N/A | 0 | ||
α-parvin shRNA Plasmid (m) | sc-60108-SH | m | Gene Silencing | Puromycin | 0 | ||
α-parvin shRNA (m) Lentivirale Partikel | sc-60108-V | m | Gene Silencing | Puromycin | 0 | ||
β-parvin siRNA (h) | sc-61301 | h | Gene Silencing | N/A | 2 | ||
β-parvin shRNA Plasmid (h) | sc-61301-SH | h | Gene Silencing | Puromycin | 2 | ||
β-parvin shRNA (h) Lentivirale Partikel | sc-61301-V | h | Gene Silencing | Puromycin | 2 | ||
β-parvin siRNA (m) | sc-61303 | m | Gene Silencing | N/A | 0 | ||
β-parvin shRNA Plasmid (m) | sc-61303-SH | m | Gene Silencing | Puromycin | 0 | ||
β-parvin shRNA (m) Lentivirale Partikel | sc-61303-V | m | Gene Silencing | Puromycin | 0 | ||
γ-parvin siRNA (h) | sc-61302 | h | Gene Silencing | N/A | 0 | ||
γ-parvin shRNA Plasmid (h) | sc-61302-SH | h | Gene Silencing | Puromycin | 0 | ||
γ-parvin shRNA (h) Lentivirale Partikel | sc-61302-V | h | Gene Silencing | Puromycin | 0 | ||
γ-parvin siRNA (m) | sc-61304 | m | Gene Silencing | N/A | 0 | ||
γ-parvin shRNA Plasmid (m) | sc-61304-SH | m | Gene Silencing | Puromycin | 0 | ||
γ-parvin shRNA (m) Lentivirale Partikel | sc-61304-V | m | Gene Silencing | Puromycin | 0 |